Pro-inflammatory T cell responses

Pro-inflammatory T cell responses represent a complex physiological process rather than a single molecular target. This process is characterized by the activation, differentiation, and clonal expansion of T lymphocyte subsets, most notably Th1 and Th17 cells, which secrete potent cytokines such as interferon-gamma, tumor necrosis factor-alpha, and interleukin-17 (Source: Nature Reviews Immunology). These responses are essential for host defense against intracellular pathogens and fungi; however, their dysregulation is a primary driver of tissue damage in autoimmune and chronic inflammatory diseases like rheumatoid arthritis, multiple sclerosis, and psoriasis (Source: Journal of Clinical Investigation). Therapeutic strategies to modulate these responses include the use of calcineurin inhibitors to prevent T cell activation, monoclonal antibodies to neutralize specific cytokines, and small molecule inhibitors to disrupt intracellular signaling (Source: StatPearls). Because this term describes a broad biological phenotype involving numerous receptors, enzymes, and signaling proteins, it is classified as a biological process rather than a discrete therapeutic target.

Other names

Th1 responseTh17 responseT-cell mediated inflammationCellular immune responseEffector T cell activation

Inhibition of T-cell receptor signaling, blockade of costimulatory molecules, neutralization of pro-inflammatory cytokines, and inhibition of downstream JAK-STAT signaling pathways.